Federal regulators recently issued a written reprimand to drug manufacturing giant, Pfizer, following reports that the company was improperly marketing several of its blockbuster products on a website for their cholesterol medication, Lipitor. The FDA faulted Pfizer for failing to properly communicate the risks associated with using several drugs including, Caduet, a pill used to [...]
